Ana Garrido

European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol

Álex Bataller, Ana Garrido, Francesca Guijarro et al. · Blood Advances · 2021 · 54 citations · Full text

Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study

Sabine Käyser, Ramy Rahmé, David Martínez‐Cuadrón et al. · Leukemia · 2020 · 49 citations · Full text

Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching

Irene García‐Cadenas, Albert Esquirol, Bosch-Vilaseca Anna et al. · Bone Marrow Transplantation · 2020 · 47 citations · Full text

Transplant Rejection, Transplantation, Solid Organ Transplantation +9

Impact of Cyclosporine Levels on the Development of Acute Graft versus Host Disease after Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

Irene García‐Cadenas, David Valcárcel, Rodrigo Martino et al. · Mediators of Inflammation · 2014 · 24 citations · Full text

Phase 1b Study of Menin-KMT2A Inhibitor Bleximenib in Combination with Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia with <i>KMT2Ar</i> or <i>NPM1</i> Alterations

Christian Récher, Jenny O’Nions, Ibrahim Aldoss et al. · Blood · 2024 · 21 citations · Full text